Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
DRMA
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
nasdaq.comPOSITIVO
Dermata Therapeutics Reports Q2 2026 Results Ahead Of First Product Launch; Stock Up
(RTTNews) - Dermata Therapeutics, Inc. (DRMA) announced financial results for the second quarter ended June 30, 2026, alongside a corporate update highlighting its transition into a commercial-stage skincare company. The San Diego-based fi…
Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln
(RTTNews) - Dermata Therapeutics Inc. (DRMA), a dermatologic firm, announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2.02 million shares of common stock and Series C and Series D warrants…
Dermata Therapeutics announces up to $12.4 million private placement
* Dermata Therapeutics (DRMA [https://seekingalpha.com/symbol/DRMA]) has entered into definitive agreements for the issuance and sale of an aggregate of 2.02M shares of common stock, series C warrants to purchase up to 2.02M shares of comm…
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum, held September 18th are now ava…
Life Science Virtual Investor Forum Agenda Announced for September 18th
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Science Virtual Investor Forum to be held September 18th. This event is co-host…
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th Dermata invites individual and institutional investors, as well as advisors and analysts, to attend on…
Dermata Therapeutics receives extension from Nasdaq panel to meet minimum bid price
Dermata Therapeutics , Inc. (NASDAQ:DRMA), whose stock has declined over 70% in the past year and currently trades at $0.69, announced Monday that it has been granted an extension by a Nasdaq panel to regain compliance with the exchange’s…
7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024
What do you call a growth stock that isn’t growing any more? The answers are many. You can call it a disappointment. A drain on your portfolio. A bad investment. Any of these are true of F-rated growth stocks, as evaluated by the Portfolio…
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Emerging Growth MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference id…
Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now
Emerging Growth MIAMI, April 02, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference id…
NKGen Biotech and Graf Acquisition Corp. IV Announce the Nomination of Two Independent Directors for the Board of Directors of the Post-Business Combination Public Company
SANTA ANA, Calif. and THE WOODLANDS, Texas, Aug. 09, 2023 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous,…
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning, trader! Rub that sleep out our your eyes because we’re going over the biggest pre-market stock movers for Thursday! Image of Wall Street with the Washington Statue present representing Pre-Market Stock Movers. Source: oneinch…
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second electric industrial vehicle line: GEL-1800 Front Loader. Snow Lake R…
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 26.1% to $2.03 in pre-market trading after surging 18% on Monday. Kaival Brands Innovations recently announced plans to launch distribution of its products in the U.K. Entas…
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (NASDAQ: XLRN) Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Innoviva, I…
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterpri…
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share agreement with Google LLC to develop its enterprise tech platform and…
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) rose 86.1% to $9.87 in pre-market trading after jumping over 80% on Friday. The company recently reported a Q2 loss of $5.13 per share. Affirm Holdings, Inc. (NASDAQ: AFRM) rose 36.4% to $92.60 i…
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among those reporting during the week. On the…